NEVVI Medicare utilization intelligence

Geography — Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (Q5104) in Medicare, the United States

Geography · Q5104 · National · CY2024
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where Q5104 is billed · every state market

Every state market that bills this code, by services, each linked to its own market page.

← Back to the market overview